Published in Gut on March 01, 1997
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Inflammation, atrophy, and gastric cancer. J Clin Invest (2007) 4.29
Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A (2002) 3.50
Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev (2010) 3.41
Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31
Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci U S A (2008) 3.17
Time trends of mortality from gastric cancer in Europe. Dig Dis Sci (2011) 2.44
Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut (1999) 2.25
Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03
East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage. Proc Natl Acad Sci U S A (2002) 1.92
cagA-positive Helicobacter pylori populations in China and The Netherlands are distinct. Infect Immun (1998) 1.84
Cellular and molecular aspects of gastric cancer. World J Gastroenterol (2006) 1.84
Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol (2010) 1.84
Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci U S A (2011) 1.81
Association between Helicobacter pylori and mortality in the NHANES III study. Gut (2013) 1.74
Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Physiol Rev (2010) 1.73
Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog (2011) 1.67
Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep (2009) 1.63
Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med (2008) 1.62
Helicobacter pylori: present status and future prospects in Japan. J Gastroenterol (2007) 1.57
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut (2007) 1.57
Helicobacter pylori infection. World J Gastroenterol (2000) 1.54
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis (2003) 1.50
Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut (2006) 1.45
Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol Cell Biol (2006) 1.43
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology (2011) 1.41
A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34
Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun (2004) 1.30
Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol (2001) 1.29
Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Lett (2008) 1.29
Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer. J Clin Microbiol (2009) 1.25
CagA C-terminal variations in Helicobacter pylori strains from Colombian patients with gastric precancerous lesions. Clin Microbiol Infect (2009) 1.25
Nitric oxide and cancer: a review. World J Surg Oncol (2013) 1.22
Association between Helicobacter pylori and gastric cancer: current knowledge and future research. World J Gastroenterol (1998) 1.22
New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol (2003) 1.21
Induction of maturation and cytokine release of human dendritic cells by Helicobacter pylori. Infect Immun (2004) 1.21
Natural history of Helicobacter pylori infection. Dig Liver Dis (2008) 1.20
Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J Biol Chem (2010) 1.18
Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol (1998) 1.17
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma. BMC Genomics (2010) 1.16
Molecular mechanisms of H. pylori associated gastric carcinogenesis. World J Gastroenterol (1999) 1.15
Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut (1998) 1.14
Comparison of four serological tests to determine the CagA or VacA status of Helicobacter pylori strains. J Clin Microbiol (1998) 1.13
Helicobacter pylori Infection and Gastric Adenocarcinoma. US Gastroenterol Hepatol Rev (2011) 1.12
CagA seropositivity associated with development of gastric cancer in a Japanese population. J Clin Pathol (1998) 1.12
Helicobacter pylori typing as a tool for tracking human migration. Clin Microbiol Infect (2009) 1.12
Multiple genes in the left half of the cag pathogenicity island of Helicobacter pylori are required for tyrosine kinase-dependent transcription of interleukin-8 in gastric epithelial cells. Infect Immun (1999) 1.11
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review. World J Exp Med (2015) 1.10
Seroprevalence of Helicobacter pylori, incidence of gastric cancer, and peptic ulcer-associated hospitalizations in a Canadian Indian population. Dig Dis Sci (1999) 1.10
Host-interactive genes in Amerindian Helicobacter pylori diverge from their Old World homologs and mediate inflammatory responses. J Bacteriol (2010) 1.10
Increased susceptibility to Helicobacter pylori infection in pregnancy. Infect Dis Obstet Gynecol (1999) 1.10
Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori. Dig Dis Sci (1998) 1.10
Assessment of Helicobacter pylori vacA and cagA genotypes and host serological response. J Clin Microbiol (2001) 1.09
Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer. J Clin Pathol (1999) 1.09
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol (2014) 1.09
Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut (2002) 1.09
Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene (2010) 1.09
High prevalence of potentially virulent strains of Helicobacter pylori in the general male British population. Gut (2000) 1.08
Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut (1998) 1.08
Gastric carcinogenesis. Langenbecks Arch Surg (2011) 1.08
Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc Natl Acad Sci U S A (2005) 1.08
Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates. J Clin Microbiol (2006) 1.07
cDNA array analysis of cag pathogenicity island-associated Helicobacter pylori epithelial cell response genes. Infect Immun (2001) 1.07
Early-life family structure and microbially induced cancer risk. PLoS Med (2007) 1.06
Comparative genomics of Helicobacter pylori isolates recovered from ulcer disease patients in England. BMC Microbiol (2005) 1.06
Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia. J Clin Pathol (2001) 1.04
Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology. Eur J Clin Microbiol Infect Dis (2003) 1.04
Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori. Eur J Epidemiol (2005) 1.04
babA2- and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J Clin Microbiol (2003) 1.03
Helicobacter pylori induces apoptosis of macrophages in association with alterations in the mitochondrial pathway. Infect Immun (2004) 1.03
The beta1 integrin activates JNK independent of CagA, and JNK activation is required for Helicobacter pylori CagA+-induced motility of gastric cancer cells. J Biol Chem (2008) 1.03
The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol (2008) 1.02
Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut (2000) 1.02
Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg (2000) 1.02
Helicobacter pylori and gastroduodenal pathology: new threats of the old friend. Ann Clin Microbiol Antimicrob (2005) 1.02
Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol (2010) 1.02
Uncovering oral Neisseria tropism and persistence using metagenomic sequencing. Nat Microbiol (2016) 1.01
A Tale of Two Toxins: Helicobacter Pylori CagA and VacA Modulate Host Pathways that Impact Disease. Front Microbiol (2010) 1.00
ABO blood group system and gastric cancer: a case-control study and meta-analysis. Int J Mol Sci (2012) 1.00
Allelic diversity and phylogeny of homB, a novel co-virulence marker of Helicobacter pylori. BMC Microbiol (2009) 1.00
Impact of Helicobacter pylori virulence factors and compounds on activation and maturation of human dendritic cells. Infect Immun (2005) 1.00
Regulation of murine dendritic cell immune responses by Helicobacter felis antigen. Infect Immun (2006) 0.99
Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol (2011) 0.99
Determination of Helicobacter pylori virulence by analysis of the cag pathogenicity island isolated from Iranian patients. Dig Liver Dis (2009) 0.99
Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer (2010) 0.98
Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev (2011) 0.98
Effect of inhibition of extracellular signal-regulated kinase 1 and 2 pathway on apoptosis and bcl-2 expression in Helicobacter pylori-infected AGS cells. Infect Immun (2003) 0.98
Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun (2001) 0.97
Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter (2008) 0.97
Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect Immun (2012) 0.97
Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development. Gut (1999) 0.96
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem (1995) 12.61
Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med (1991) 11.98
Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res (1995) 11.07
Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science (1993) 7.86
Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet (1991) 6.73
Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem (1994) 6.09
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest (1995) 6.02
The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev (1986) 5.10
Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun (1995) 4.19
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86
Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol (1995) 3.23
Construction of a Helicobacter pylori genome map and demonstration of diversity at the genome level. J Bacteriol (1992) 3.16
Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun (1995) 2.23
Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol (1994) 1.74
High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol (1992) 1.54
Intrastrain differences in Helicobacter pylori: a key question in mucosal damage? Ann Med (1995) 1.37
The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol (1989) 1.36
ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect (1991) 1.30
Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol Suppl (1994) 1.29
Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl (1991) 1.28
Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst (1992) 1.18
Gastric cancer among the Japanese in Hawaii. Jpn J Cancer Res (1995) 1.08
Genetic diversity of Helicobacter pylori indexed with respect to clinical symptomatology, using a 16S rRNA and a species-specific DNA probe. J Appl Bacteriol (1993) 1.02
Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 0.99
Predictors of future breast cancer risk. Cancer Epidemiol Biomarkers Prev (1993) 0.88
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med (1992) 10.70
Helicobacter pylori infection and gastric lymphoma. N Engl J Med (1994) 10.26
Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst (1994) 5.92
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Alcohol consumption and blood pressure Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med (1977) 4.53
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Recruitment in the Coronary Artery Disease Risk Development in Young Adults (Cardia) Study. Control Clin Trials (1987) 4.05
Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels. Am J Public Health (1992) 3.47
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab (1984) 3.07
Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health (1981) 3.00
Social class and racial differences in blood pressure. Am J Public Health (1974) 2.91
Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev (1993) 2.82
Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med (1999) 2.57
Alcohol and mortality. Ann Intern Med (1992) 2.49
Alcohol and mortality. A ten-year Kaiser-Permanente experience. Ann Intern Med (1981) 2.48
Cigarette smoking behavior is strongly related to educational status: the CARDIA study. Prev Med (1990) 2.47
Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia (1987) 2.44
Systolic hypertension in the elderly. An epidemiologic assessment. Circulation (1970) 2.42
Characteristics of patients referred for treatment of end-stage renal disease in a defined population. Am J Public Health (1982) 2.29
Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol (1990) 2.27
Subcutaneous incisionless (subcision) surgery for the correction of depressed scars and wrinkles. Dermatol Surg (1995) 2.25
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25
Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis (1986) 2.24
The leukocyte count as a predictor of myocardial infarction. N Engl J Med (1974) 2.22
Smoking habits and the leukocyte count. Arch Environ Health (1973) 2.22
Coffee, tea, and mortality. Ann Epidemiol (1993) 2.17
Methionine restriction increases blood glutathione and longevity in F344 rats. FASEB J (1994) 2.08
Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med (1976) 2.00
Prostate-specific antigen as predictor of prostate cancer in black men and white men. J Natl Cancer Inst (1995) 1.96
Cigarettes, alcohol, coffee and peptic ulcer. N Engl J Med (1974) 1.95
Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol (1990) 1.90
Cigarette smoking and serum chemistry tests. J Chronic Dis (1974) 1.85
Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study. Ann Intern Med (1993) 1.82
Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer (2001) 1.80
The relations of alcoholic beverage use to colon and rectal cancer. Am J Epidemiol (1988) 1.78
Coffee drinking prior to acute myocardial infarction. Results from the Kaiser-Permanente Epidemiologic Study of Myocardial Infarction. JAMA (1973) 1.77
Red wine, white wine, liquor, beer, and risk for coronary artery disease hospitalization. Am J Cardiol (1997) 1.76
Prevalence and correlates of passive smoking. Am J Public Health (1983) 1.71
Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System. JAMA (1971) 1.71
Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol (1982) 1.70
Pain tolerance: differences according to age, sex and race. Psychosom Med (1973) 1.70
Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle-aged men. Prev Med (1973) 1.70
Hair transplantation: the punch graft technique. Surg Clin North Am (1971) 1.65
Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med (1981) 1.60
Gastrin and colorectal cancer: a prospective study. Gastroenterology (1998) 1.57
Mentholated cigarette use among multiphasic examinees, 1979-86. Am J Public Health (1989) 1.56
Comparison of prevalence, case history and incidence data in assessing the potency of risk factors in coronary heart disease. Am J Epidemiol (1966) 1.56
Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med (1974) 1.49
The frequency of kidney and urinary tract diseases in a defined population. Kidney Int (1982) 1.49
Alcohol intake and blood pressure in young adults: the CARDIA Study. J Clin Epidemiol (1990) 1.48
Marijuana use and mortality. Am J Public Health (1997) 1.47
The relationships between alcoholic beverage use and other traits to blood pressure: a new Kaiser Permanente study. Circulation (1986) 1.47
Multiphasic checkup evaluation study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Prev Med (1973) 1.46
Long-term risk of hysterectomy among 80,007 sterilized and comparison women at Kaiser Permanente, 1971-1987. Am J Epidemiol (1993) 1.45
Cholecystectomy and the risk of colon cancer. Am J Gastroenterol (1999) 1.45
Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am J Cardiol (1986) 1.44
Health care use by frequent marijuana smokers who do not smoke tobacco. West J Med (1993) 1.44
Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. Am J Epidemiol (1987) 1.43
Inconsistent associations of caffeine-containing beverages with blood pressure and with lipoproteins. The CARDIA Study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (1993) 1.42
Mentholated cigarette use and lung cancer. Arch Intern Med (1995) 1.41
Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res (1989) 1.41
Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol (1996) 1.39
US Preventive Services Task Force. Automobile injury--selected risk factors and prevention in the health care setting. JAMA (1988) 1.38
Mortality in cigarette smokers and quitters. Effect of base-line differences. N Engl J Med (1981) 1.37
A case-control study of relationships of diet and other traits to colorectal cancer in American blacks. Am J Epidemiol (1979) 1.36
Initial screening for carcinogenicity of commonly used drugs. J Natl Cancer Inst (1980) 1.32
An evaluation of follow-up methods in the Framingham Heart Study. Am J Public Health Nations Health (1967) 1.31
Multiphasic checkup evaluation study. 1. Methods and population. Prev Med (1973) 1.30
Smoking habits among multiphasic examinees, 1979 to 1984. West J Med (1986) 1.28
Characteristics predictive of coronary heart disease in ex-smokers before they stopped smoking: comparison with persistent smokers and nonsmokers. J Chronic Dis (1979) 1.26
Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology (1992) 1.24
Smoking among white, black, and yellow men and women. Kaiser-Permanente multiphasic health examination data, 1964-1968. Am J Epidemiol (1972) 1.23
Hearing loss in adults: relation to age, sex, exposure to loud noise, and cigarette smoking. Arch Environ Health (1974) 1.20
Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev (1998) 1.19
Screening for possible drug carcinogenicity: second report of findings. J Natl Cancer Inst (1983) 1.18
Evaluating periodic multiphasic health checkups: a controlled trial. J Chronic Dis (1979) 1.16
Differences in pulmonary function related to smoking habits and race. Am Rev Respir Dis (1974) 1.16
Exposure to environmental tobacco smoke: association with personal characteristics and self reported health conditions. J Epidemiol Community Health (2001) 1.15
Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control (1992) 1.15
Alcohol intake and hypertension. Ann Intern Med (1983) 1.14
Colon cancer screening, lifestyle, and risk of colon cancer. Cancer Causes Control (2000) 1.14
Mortality in middle-aged smokers and nonsmokers. N Engl J Med (1979) 1.14
Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Prev Med (1973) 1.14
Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. Am J Epidemiol (1990) 1.14
Racial patterns of alcoholic beverage use. Alcohol Clin Exp Res (1983) 1.14
Antibodies to hair follicles in alopecia areata. J Invest Dermatol (1994) 1.13
Relationship of stroke to other cardiovascular disease. Circulation (1968) 1.13
Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA (1991) 1.13
Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health (1990) 1.12
Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation (1993) 1.11
Changes after quitting cigarette smoking. Circulation (1980) 1.11
Transient ischemic attacks in a community. JAMA (1969) 1.11
Mail survey response by health status of smokers, nonsmokers, and ex-smokers. Am J Epidemiol (1973) 1.10